Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.
The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets.
Contact
Unit 2808, Changning Raffles City Tower 2, #1189 Changning Road, Shanghai, China
Website: http://www.ternspharma.com.cn/
Email: connect@ternspharma.com